Invasive and Non-invasive Haemodynamic Assessment of Pulmonary Hypertension in Chronic Kidney Disease Patient
1 other identifier
observational
75
0 countries
N/A
Brief Summary
Patients with CKD who suspected to have pulmonary hypertension by echocardiography with high probability, RHC used to confirm the diagnosis, assessment of hemodynamic parameters, differentiate pre and post capillary types of pulmonary hypertension and asses severity of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
July 8, 2025
May 1, 2025
10 months
May 17, 2025
July 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis of pulmonary hypertention in chronic kidney diseaes patients and identify its type and guide management.
Hemodynamic assessment by echo including (right atrial surface area, right ventricular diameters, tricuspid annular plane systolic excursion ,tricusped regureg Jet velocity, inferior vena cava diameter and inspiratory collapability, estimated pulmonary artery pressure and left ventricular structure and function) and Hemodynamic assessment by RHC to diagnose and identify tyoe of PH according theses parameters a mean pulmonary arterial pressure (mPAP) \>20 mm Hg, pulmonary artery wedge pressure (PAWP) ≤15mmHg and a PVR \> 2WU. Pre-capillary PH ,mPAP \>20 mmHg,PAWP ≤15mmHg,PVR ≥3WU.Isolated post-capillary PH (IpcPH),mPAP \>20 mmHg,PAWP \>15mmHg,PVR \<3WU. Combined pre- and post-capillary PH (CpcPH),mPAP \>20 mmHg,PAWP \>15mmHg,PVR ≥3WU.Descriptive statistics will be done in the form of frequencies, mean and SD then analytic statistics will be done as chi square, independent sample test, correlations and regression tests, paired t-test will be
One year
Interventions
Echocardiography is the non invasvive interventional assessment and the RHC is the invasive international assessment of the hemodynamics in PH patients with ckd.
Eligibility Criteria
Admitted patients in Internal medicine department, Critical care unit and pulmonary hypertension unit chest department at Assuit University Hospital.
You may qualify if:
- \- All adult (aged 18 years old and older) patients who were diagnosed CKD(The presence of kidney damage or an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m², persisting for 3 months or more) and suspected to have pulmonary hypertension by clinical feature or by echocardiography with high probability were included in this study.
You may not qualify if:
- Patients under 18 years old
- Patient with chronic chest disease.
- Patient bleeding diathesis and high risk of bleeding.
- Individuals having acute kidney injury.
- Patient developing other PH aetiologies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Jankowich M, Hebel R, Jantz J, Abbasi S, Choudhary G. Multispecialty pulmonary hypertension clinic in the VA. Pulm Circ. 2017 Oct-Dec;7(4):758-767. doi: 10.1177/2045893217726063. Epub 2017 Aug 22.
PMID: 28770656BACKGROUNDPugh ME, Hemnes AR, Trammell A, Newman JH, Robbins IM. Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers. Pulm Circ. 2014 Dec;4(4):679-84. doi: 10.1086/678514.
PMID: 25610603BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr,
Study Record Dates
First Submitted
May 17, 2025
First Posted
July 8, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
July 8, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share